{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:54:24Z","timestamp":1783349664797,"version":"3.54.6"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071637210","type":"print"},{"value":"9781071637227","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3722-7_27","type":"book-chapter","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:02:12Z","timestamp":1715947332000},"page":"393-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines"],"prefix":"10.1007","author":[{"given":"Charles A.","family":"Specht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woei C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen M.","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lourenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Levitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Lodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Upadhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2334-10-199","volume":"10","author":"TT Chau","year":"2010","unstructured":"Chau TT, Mai NH, Phu NH et al (2010) A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis 10:199. https:\/\/doi.org\/10.1186\/1471-2334-10-199","journal-title":"BMC Infect Dis"},{"issue":"5","key":"27_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3201\/eid1405.071312","volume":"14","author":"J Chen","year":"2008","unstructured":"Chen J, Varma A, Diaz MR et al (2008) Cryptococcus neoformans strains and infection in apparently immunocompetent patients. China Emerg Infect Dis 14(5):755\u2013762. https:\/\/doi.org\/10.3201\/eid1405.071312","journal-title":"China Emerg Infect Dis"},{"issue":"2","key":"27_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/s-2008-1063853","volume":"29","author":"JN Jarvis","year":"2008","unstructured":"Jarvis JN, Harrison TS (2008) Pulmonary cryptococcosis. Semin Respir Crit Care Med 29(2):141\u2013150. https:\/\/doi.org\/10.1055\/s-2008-1063853","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"27_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000850","volume":"6","author":"EJ Byrnes 3rd","year":"2010","unstructured":"Byrnes EJ 3rd, Li W, Lewit Y et al (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the Northwest United States. PLoS Pathog 6(4):e1000850. https:\/\/doi.org\/10.1371\/journal.ppat.1000850","journal-title":"PLoS Pathog"},{"issue":"12","key":"27_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","volume":"22","author":"R Rajasingham","year":"2022","unstructured":"Rajasingham R, Govender NP, Jordan A et al (2022) The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis 22(12):1748\u20131755. https:\/\/doi.org\/10.1016\/S1473-3099(22)00499-6","journal-title":"Lancet Infect Dis"},{"key":"27_CR6","volume-title":"WHO. Fungal priority pathogens list to guide research, development and public health action","author":"WHO","year":"2022","unstructured":"WHO (2022) WHO. Fungal priority pathogens list to guide research, development and public health action. World Health Organization, Geneva"},{"issue":"2","key":"27_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12281-010-0018-6","volume":"4","author":"MD Johnson","year":"2010","unstructured":"Johnson MD, Perfect JR (2010) Use of antifungal combination therapy: agents, order, and timing. Curr Fungal Infect Rep 4(2):87\u201395. https:\/\/doi.org\/10.1007\/s12281-010-0018-6","journal-title":"Curr Fungal Infect Rep"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.fgb.2014.12.001","volume":"78","author":"DJ Krysan","year":"2015","unstructured":"Krysan DJ (2015) Toward improved anti-cryptococcal drugs: novel molecules and repurposed drugs. Fungal Genet Biol 78:93\u201398. https:\/\/doi.org\/10.1016\/j.fgb.2014.12.001","journal-title":"Fungal Genet Biol"},{"issue":"12","key":"27_CR9","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.1128\/AAC.01299-15","volume":"59","author":"KD Smith","year":"2015","unstructured":"Smith KD, Achan B, Huppler Hullsiek K et al (2015) Increased antifungal drug resistance in Ugandan clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother 59(12):7197\u20137204. https:\/\/doi.org\/10.1128\/AAC.01299-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"27_CR10","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.41.11.2326","volume":"41","author":"K Bartizal","year":"1997","unstructured":"Bartizal K, Gill CJ, Abruzzo GK et al (1997) In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743, 872). Antimicrob Agents Chemother 41(11):2326\u20132332. https:\/\/doi.org\/10.1128\/AAC.41.11.2326","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"27_CR11","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1128\/AAC.41.11.2333","volume":"41","author":"GK Abruzzo","year":"1997","unstructured":"Abruzzo GK, Flattery AM, Gill CJ et al (1997) Evaluation of the echinocandin antifungal MK-0991 (L-743, 872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 41(11):2333\u20132338. https:\/\/doi.org\/10.1128\/AAC.41.11.2333","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"27_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1586\/14760584.2013.840094","volume":"12","author":"AK Chaturvedi","year":"2013","unstructured":"Chaturvedi AK, Wormley FL Jr (2013) Cryptococcus antigens and immune responses: implications for a vaccine. Expert Rev Vaccines 12(11):1261\u20131272. https:\/\/doi.org\/10.1586\/14760584.2013.840094","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"27_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00281-014-0460-6","volume":"37","author":"SM Levitz","year":"2015","unstructured":"Levitz SM, Huang H, Ostroff GR et al (2015) Exploiting fungal cell wall components in vaccines. Semin Immunopathol 37(2):199\u2013207. https:\/\/doi.org\/10.1007\/s00281-014-0460-6","journal-title":"Semin Immunopathol"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-4939-7104-6_11","volume":"1625","author":"Z Mirza","year":"2017","unstructured":"Mirza Z, Soto ER, Dikengil F et al (2017) Beta-glucan particles as vaccine adjuvant carriers. Methods Mol Biol 1625:143\u2013157. https:\/\/doi.org\/10.1007\/978-1-4939-7104-6_11","journal-title":"Methods Mol Biol"},{"issue":"3","key":"27_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.vaccine.2019.10.051","volume":"38","author":"MM Hester","year":"2020","unstructured":"Hester MM, Lee CK, Abraham A et al (2020) Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens. Vaccine 38(3):620\u2013626. https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.051","journal-title":"Vaccine"},{"issue":"1","key":"27_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03367-21","volume":"13","author":"CA Specht","year":"2021","unstructured":"Specht CA, Homan EJ, Lee CK et al (2021) Protection of mice against experimental cryptococcosis by synthesized peptides delivered in glucan particles. MBio 13(1):e0336721. https:\/\/doi.org\/10.1128\/mbio.03367-21","journal-title":"MBio"},{"issue":"3","key":"27_CR17","doi-asserted-by":"publisher","first-page":"e00547","DOI":"10.1128\/mBio.00547-16","volume":"7","author":"R Upadhya","year":"2016","unstructured":"Upadhya R, Lam WC, Maybruck B et al (2016) Induction of protective immunity to cryptococcal infection in mice by a heat-killed, chitosan-deficient strain of Cryptococcus neoformans. mBio 7(3):e00547\u2013e00516. https:\/\/doi.org\/10.1128\/mBio.00547-16","journal-title":"mBio"},{"issue":"3","key":"27_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1128\/IAI.00274-06","volume":"75","author":"FL Wormley Jr","year":"2007","unstructured":"Wormley FL Jr, Perfect JR, Steele C et al (2007) Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun 75(3):1453\u20131462. https:\/\/doi.org\/10.1128\/IAI.00274-06","journal-title":"Infect Immun"},{"key":"27_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2021.100066","volume":"7","author":"R Upadhya","year":"2021","unstructured":"Upadhya R, Lam WC, Hole CR et al (2021) Cryptococcus neoformans Cda1 and Cda2 coordinate deacetylation of chitin during infection to control fungal virulence. Cell Surf 7:100066. https:\/\/doi.org\/10.1016\/j.tcsw.2021.100066","journal-title":"Cell Surf"},{"issue":"1","key":"27_CR20","doi-asserted-by":"publisher","first-page":"e01828","DOI":"10.1128\/mBio.01828-17","volume":"9","author":"J Masso-Silva","year":"2018","unstructured":"Masso-Silva J, Espinosa V, Liu TB et al (2018) The F-box protein Fbp1 shapes the immunogenic potential of Cryptococcus neoformans. mBio 9(1):e01828\u2013e01817. https:\/\/doi.org\/10.1128\/mBio.01828-17","journal-title":"mBio"},{"key":"27_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fmicb.2015.00836","volume":"6","author":"A Rella","year":"2015","unstructured":"Rella A, Mor V, Farnoud AM et al (2015) Role of sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development. Front Microbiol 6:836. https:\/\/doi.org\/10.3389\/fmicb.2015.00836","journal-title":"Front Microbiol"},{"issue":"5","key":"27_CR22","doi-asserted-by":"publisher","first-page":"e01433","DOI":"10.1128\/mBio.01433-15","volume":"6","author":"B Zhai","year":"2015","unstructured":"Zhai B, Wozniak KL, Masso-Silva J et al (2015) Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio 6(5):e01433\u2013e01415. https:\/\/doi.org\/10.1128\/mBio.01433-15","journal-title":"mBio"},{"issue":"5","key":"27_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tim.2017.10.002","volume":"26","author":"MC Caballero Van Dyke","year":"2018","unstructured":"Caballero Van Dyke MC, Wormley FL Jr (2018) A call to arms: quest for a cryptococcal vaccine. Trends Microbiol 26(5):436\u2013446. https:\/\/doi.org\/10.1016\/j.tim.2017.10.002","journal-title":"Trends Microbiol"},{"issue":"5","key":"27_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1084\/jem.111.5.643","volume":"111","author":"DB Louria","year":"1960","unstructured":"Louria DB (1960) Specific and non-specific immunity in experimental cryptococcosis in mice. J Exp Med 111(5):643\u2013665. https:\/\/doi.org\/10.1084\/jem.111.5.643","journal-title":"J Exp Med"},{"key":"27_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/infdis\/107.3.406","volume":"107","author":"HH Gadebusch","year":"1960","unstructured":"Gadebusch HH (1960) Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. III. Antibody stimulation by partially decapsulated cells. J Infect Dis 107:406\u2013409. https:\/\/doi.org\/10.1093\/infdis\/107.3.406","journal-title":"J Infect Dis"},{"issue":"2","key":"27_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/00362178385380181","volume":"21","author":"RA Fromtling","year":"1983","unstructured":"Fromtling RA, Kaplan AM, Shadomy HJ (1983) Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans. Sabouraudia 21(2):113\u2013119","journal-title":"Sabouraudia"},{"issue":"6","key":"27_CR27","doi-asserted-by":"publisher","first-page":"e02145","DOI":"10.1128\/mBio.02145-19","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang K, Masso-Silva JA et al (2019) A heat-killed Cryptococcus mutant strain induces host protection against multiple invasive mycoses in a murine vaccine model. mBio 10(6):e02145\u2013e02119. https:\/\/doi.org\/10.1128\/mBio.02145-19","journal-title":"mBio"},{"issue":"9","key":"27_CR28","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1128\/IAI.71.9.4831-4841.2003","volume":"71","author":"K Nielsen","year":"2003","unstructured":"Nielsen K, Cox GM, Wang P et al (2003) Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun 71(9):4831\u20134841","journal-title":"Infect Immun"},{"key":"27_CR29","volume-title":"Biosafety in Microbiological and Biomedical Laboratories","author":"J Matthew","year":"2020","unstructured":"Matthew J, Arduino WDA, Bailin H et al (2020) Biosafety in Microbiological and Biomedical Laboratories, 6th edn. U.S. Department of Health and Human Services Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health, HHS Publication No. (CDC) 300859","edition":"6"}],"container-title":["Methods in Molecular Biology","Cryptococcus neoformans"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3722-7_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:03:51Z","timestamp":1715947431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3722-7_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637210","9781071637227"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3722-7_27","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"18 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}